← Back to Compounds
oralanabolic

Stanozolol

WinstrolWinnyStano
320
Anabolic Ratio
30
Androgenic Ratio
0.375d
Half-Life

DHT-derived oral. Dry, hard look — no water retention. Poor joint lubrication (notorious for joint pain). Significant cholesterol impact. Often used pre-contest for vascularity.

Mechanism of Action

Does NOT aromatize. Binds AR and SHBG with high affinity (frees more testosterone). Strongly reduces HDL and increases LDL — one of the most concerning cardiovascular profiles among common AAS.

Stanozolol molecule
Molecular structure

Typical Dosing

210 mg
low / week
350 mg
moderate / week
700 mg
high / week

⚠ Warning Flags

  • •Severe HDL reduction — worst cardiovascular impact of common oral AAS
  • •Joint pain / tendon dryness common
  • •Oral 17α-alkylated — limit use to ≤6 weeks

Effect Profile

Muscle Protein Synthesis
5Moderate
Nitrogen Retention
5Moderate
Strength Gains
6Moderate
Red Blood Cell Production
3Low
Fat Loss
5Moderate
Glycogen Storage
3Low
Recovery Speed
4Low
Collagen Synthesis
2Minimal

Side Effect Profile

Hormonal Suppression
5Moderate
Estrogenic Effects
1Minimal
Androgenic Effects
4Low
Cardiovascular Strain
7High
Liver Stress
6Moderate
Insulin Resistance
2Minimal
Mood Changes
4Low
Prostate Risk
3Low

Research Studies

Metabolic and ventilatory effects of stanozolol in rats and humans

Lewis MI, et al. · 1999

PubMed

Stanozolol demonstrated strong lipid-lowering effects on HDL cholesterol — one of the most detrimental AAS cardiovascular profiles observed.